piracetam has been researched along with Learning Disabilities in 23 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Learning Disabilities: Conditions characterized by a significant discrepancy between an individual's perceived level of intellect and their ability to acquire new language and other cognitive skills. These may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, DYSCALCULIA, and DYSGRAPHIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the prevalence and psychopathological features of psychiatric adverse events (PAEs) in patients with learning disabilities (LD) in therapy with levetiracetam (LEV)." | 7.72 | Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam. ( Mula, M; Sander, JW; Trimble, MR, 2004) |
| "The purpose was to evaluate the effects of levetiracetam (LEV) in routine therapy in learning disabled patients with therapy-resistant epilepsy." | 7.72 | Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities. ( Bömmel, W; Hauser, I; Horstmann, V; Huber, B; Liem, S; May, T; Meinert, T; Robertson, E; Schulz, L; Seidel, M; Tomka-Hoffmeister, M; Wagner, W, 2004) |
| "Levetiracetam was generally well tolerated." | 6.74 | The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production. ( Brown, M; Legoff, D; Levin-Allen, S; Mintz, M; Mintz, P; Scornaienchi, J; Smith, C, 2009) |
| "Levetiracetam is a new anticonvulsant (AED) with a novel mechanism of action." | 5.31 | Levetiracetam psychosis in children with epilepsy. ( Bergey, GK; Freeman, JM; Kossoff, EH; Vining, EP, 2001) |
| "To investigate the prevalence and psychopathological features of psychiatric adverse events (PAEs) in patients with learning disabilities (LD) in therapy with levetiracetam (LEV)." | 3.72 | Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam. ( Mula, M; Sander, JW; Trimble, MR, 2004) |
| "The purpose was to evaluate the effects of levetiracetam (LEV) in routine therapy in learning disabled patients with therapy-resistant epilepsy." | 3.72 | Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities. ( Bömmel, W; Hauser, I; Horstmann, V; Huber, B; Liem, S; May, T; Meinert, T; Robertson, E; Schulz, L; Seidel, M; Tomka-Hoffmeister, M; Wagner, W, 2004) |
| "Levetiracetam was generally well tolerated." | 2.74 | The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production. ( Brown, M; Legoff, D; Levin-Allen, S; Mintz, M; Mintz, P; Scornaienchi, J; Smith, C, 2009) |
| "Piracetam was compared with placebo in a double-blind cross-over study of 30 learning disabled boys." | 2.65 | Effect of piracetam on EEG spectra of boys with learning disorders. ( Cho, D; Reker, D; Simeon, J; Simeon, S; Volavka, J, 1981) |
| "Aniracetam was administered to 1-month-old rats, demonstrating a prolonged (2 months) therapeutic effect, observed in rats aged 3 months." | 1.31 | Can nootropic drugs be effective against the impact of ethanol teratogenicity on cognitive performance? ( Vaglenova, J; Vesselinov Petkov, V, 2001) |
| "Levetiracetam is a new anticonvulsant (AED) with a novel mechanism of action." | 1.31 | Levetiracetam psychosis in children with epilepsy. ( Bergey, GK; Freeman, JM; Kossoff, EH; Vining, EP, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (43.48) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McNally, MA | 1 |
| Kossoff, EH | 2 |
| Mintz, M | 1 |
| Legoff, D | 1 |
| Scornaienchi, J | 1 |
| Brown, M | 1 |
| Levin-Allen, S | 1 |
| Mintz, P | 1 |
| Smith, C | 1 |
| Sharma, K | 1 |
| Bhatnagar, M | 1 |
| Kulkarni, SK | 1 |
| Mula, M | 1 |
| Trimble, MR | 1 |
| Sander, JW | 1 |
| Huber, B | 1 |
| Bömmel, W | 1 |
| Hauser, I | 1 |
| Horstmann, V | 1 |
| Liem, S | 1 |
| May, T | 1 |
| Meinert, T | 1 |
| Robertson, E | 1 |
| Schulz, L | 1 |
| Seidel, M | 1 |
| Tomka-Hoffmeister, M | 1 |
| Wagner, W | 1 |
| Chappell, B | 1 |
| Crawford, P | 1 |
| Chen, J | 1 |
| Long, Y | 1 |
| Han, M | 1 |
| Wang, T | 1 |
| Chen, Q | 1 |
| Wang, R | 1 |
| Gualtieri, CT | 1 |
| Golden, RN | 1 |
| Fahs, JJ | 1 |
| Volavka, J | 1 |
| Simeon, J | 3 |
| Simeon, S | 1 |
| Cho, D | 1 |
| Reker, D | 1 |
| Waters, B | 2 |
| Resnick, M | 2 |
| Trites, R | 1 |
| Fiedorowicz, C | 1 |
| Trofimov, SS | 3 |
| Ostrovskaia, RU | 2 |
| Kravchenko, EV | 2 |
| Smol'nikova, NM | 2 |
| Bondarenko, NA | 1 |
| Kutepova, OA | 1 |
| Nemova, EP | 2 |
| Voronina, TA | 3 |
| Krylov, IN | 1 |
| Iasnetsov, VV | 1 |
| Dukhanin, AS | 1 |
| Pal'tsev, IuP | 1 |
| Vaglenova, J | 1 |
| Vesselinov Petkov, V | 1 |
| Bergey, GK | 1 |
| Freeman, JM | 1 |
| Vining, EP | 1 |
| Mönikes, HJ | 1 |
| Leary, PM | 2 |
| Machanick, S | 1 |
| Arens, LJ | 1 |
| Rabkin, J | 1 |
| Logue, GD | 1 |
| Garibova, TL | 1 |
| Sopyev, ZhA | 1 |
| Petkov, VD | 1 |
| Lazarova, MB | 1 |
| Wilsher, CR | 1 |
2 reviews available for piracetam and Learning Disabilities
| Article | Year |
|---|---|
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder | 1983 |
Effects of piracetam on developmental dyslexia.
Topics: Animals; Cerebral Cortex; Clinical Trials as Topic; Conditioning, Operant; Corpus Callosum; Dogs; Do | 1986 |
5 trials available for piracetam and Learning Disabilities
| Article | Year |
|---|---|
The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production.
Topics: Adolescent; Anticonvulsants; Attention; Attention Deficit and Disruptive Behavior Disorders; Brain; | 2009 |
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder | 1983 |
Effect of piracetam on EEG spectra of boys with learning disorders.
Topics: Adolescent; Brain; Child; Delta Rhythm; Electroencephalography; Humans; Learning Disabilities; Male; | 1981 |
Letter: Piracetam and pyrithioxine.
Topics: Child; Clinical Trials as Topic; Humans; Learning Disabilities; Piracetam; Placebos; Pyrrolidinones | 1975 |
Effects of piracetam on developmental dyslexia.
Topics: Animals; Cerebral Cortex; Clinical Trials as Topic; Conditioning, Operant; Corpus Callosum; Dogs; Do | 1986 |
18 other studies available for piracetam and Learning Disabilities
| Article | Year |
|---|---|
Incidental rolandic spikes: long-term outcomes and impact of treatment.
Topics: Anticonvulsants; Child; Child, Preschool; Electroencephalography; Epilepsy, Rolandic; Female; Follow | 2015 |
Effect of Convolvulus pluricaulis Choisy and Asparagus racemosus Willd on learning and memory in young and old mice: a comparative evaluation.
Topics: Acetylcholine; Aging; Animals; Antioxidants; Cholinergic Agents; Convolvulus; Dose-Response Relation | 2010 |
Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam.
Topics: Adult; Analysis of Variance; Anticonvulsants; Behavioral Symptoms; Chi-Square Distribution; Epilepsy | 2004 |
Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities.
Topics: Adolescent; Adult; Aged; Epilepsy; Female; Humans; Learning Disabilities; Levetiracetam; Male; Middl | 2004 |
An audit of lamotrigine, levetiracetam and topiramate usage for epilepsy in a district general hospital.
Topics: Adult; Aged; Anticonvulsants; Cohort Studies; Drug Utilization; Epilepsy; Epilepsy, Generalized; Fem | 2005 |
Water-soluble derivative of propolis mitigates scopolamine-induced learning and memory impairment in mice.
Topics: Acetylcholinesterase; Animals; Arginine; Cerebral Cortex; Chromatography, High Pressure Liquid; Hipp | 2008 |
An adverse reaction to piracetam in an hypothyroid 10 year old boy.
Topics: Brain Diseases; Child; Double-Blind Method; Humans; Hypothyroidism; Learning Disabilities; Male; Pir | 1980 |
Effects of piracetam in children with learning disorders.
Topics: Adolescent; Child; Double-Blind Method; Humans; Learning Disabilities; Male; Piracetam; Pyrrolidinon | 1980 |
[Behavior disorders in rats exposed to intrauterine hypoxia, and their correction by postnatal treatment with piracetam].
Topics: Animals; Behavior, Animal; Female; Fetal Hypoxia; Learning Disabilities; Memory Disorders; Piracetam | 1993 |
[Pharmacologic correction of learning and memory disorders induced by exposure to high-frequency electromagnetic radiation].
Topics: Animals; Learning Disabilities; Male; Memory Disorders; Microwaves; Naloxone; Piracetam; Psychotropi | 1993 |
[Piracetam as a corrector of long-term learning disorders caused by prenatal alcohol exposure: the significance of the length of therapy].
Topics: Animals; Avoidance Learning; Ethanol; Female; Learning Disabilities; Male; Nootropic Agents; Piracet | 1996 |
Can nootropic drugs be effective against the impact of ethanol teratogenicity on cognitive performance?
Topics: Alcohol-Induced Disorders, Nervous System; Animals; Disease Models, Animal; Female; Learning Disabil | 2001 |
Levetiracetam psychosis in children with epilepsy.
Topics: Acute Disease; Adolescent; Anticonvulsants; Child, Preschool; Comorbidity; Drug Administration Sched | 2001 |
[Legasthenia. Diagnosis, therapy--experiences in a child and adolescent psychiatric ambulatory].
Topics: Adolescent; Ambulatory Care; Child; Child Behavior Disorders; Dyslexia; Female; Handwriting; Humans; | 1977 |
Piracetam in the management of minimal brain dysfunction.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Humans; Learning Disabilities; Piracetam; Pyrr | 1976 |
Letter: Piracetam and pyrithioxine.
Topics: Animals; Blood-Brain Barrier; Cerebral Cortex; Child; Humans; Learning Disabilities; Piracetam; Pyri | 1975 |
Letter: Pyracetam and pyrithioxine.
Topics: Age Factors; Child; Child, Preschool; Humans; Learning Disabilities; Piracetam; Pyridines; Pyrithiox | 1975 |
Comparative studies on the influence of ONK (N(5-hydroxynicotinoil) glutamic acid), piracetam and meclofenoxate on the learning- and memory-impairing effect of scopolamine, clonidine, and methergoline.
Topics: Animals; Avoidance Learning; Clonidine; Glutamates; Learning Disabilities; Male; Meclofenoxate; Memo | 1991 |